Intermittent preventive treatment in pregnancy ( IPTp ) with sulfadoxine-pyrimethamine ( SP ) is recommended for malaria prevention in HIV-negative pregnant women , but it is contraindicated in HIV-infected women taking daily cotrimoxazole prophylaxis ( CTXp ) because of potential added risk of adverse effects associated with taking two antifolate drugs simultaneously .